CME Group Inc.

NasdaqGS:CME Stok Raporu

Piyasa değeri: US$94.8b

CME Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

CME Group kazanç ve gelirin sırasıyla yıllık 3.4% ve 5.1% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 5.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 16.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

3.4%

Kazanç büyüme oranı

5.12%

EPS büyüme oranı

Capital Markets kazanç büyümesi12.1%
Gelir büyüme oranı5.1%
Gelecekteki özkaynak getirisi16.34%
Analist kapsamı

Good

Son güncelleme03 Aug 2026

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Anlatı Güncellemesi • Jul 28

CME: Perpetual Futures Dispute And New Contracts Will Shape Earnings Profile

The analyst fair value estimate for CME Group has been trimmed by about $6.64 to $282.36, as analysts balance slightly higher projected revenue growth with lower profit margin assumptions and a modestly reduced future P/E multiple following a mix of recent target cuts and increases across the Street. Analyst Commentary Recent research on CME Group shows a split view, with some firms lifting price targets and ratings while others trim expectations and flag competitive threats.
Seeking Alpha • Jul 23

CME Group's Strong Quarter Still Supports A Hold

Summary CME Group maintains strong core performance, posting record Q2 revenue and robust margins, yet the stock remains range-bound and fully valued. Q2 2026 highlights include $2.99 non-GAAP EPS, $1.71B revenue, 69.5% adjusted operating margin, and resilient trading volumes across key product lines. Capital return remains aggressive with $1.2B distributed via dividends and buybacks, backed by a strong balance sheet and disciplined expense management. I maintain a hold rating as CME's valuation prices in near-perfect execution, with limited upside absent major catalysts or volatility spikes. Read the full article on Seeking Alpha
Anlatı Güncellemesi • Jul 09

CME: Crypto Perpetual Futures Dispute Will Reshape Long Term Earnings Power

The analyst price target for CME Group has been trimmed by about $14 to reflect slightly softer revenue growth assumptions, a modestly higher discount rate, and lower future P/E multiples that many analysts link to competitive concerns around perpetual futures, despite broadly constructive views on the core franchise. Analyst Commentary Recent research on CME Group highlights a split view, with some analysts seeing attractive upside after the share pullback and others focusing on competitive threats and pricing pressure.
Anlatı Güncellemesi • Jun 24

CME: Crypto Perpetual Futures Dispute Will Shape Future Earnings Power

The analyst price target for CME Group has shifted slightly lower, with fair value moving from about $306.47 to $302.60 as analysts weigh ongoing concerns around perpetual futures and potential multiple compression against views that recent share weakness and structural demand drivers still support an attractive long term setup. Analyst Commentary Recent research on CME Group shows a split between bullish analysts who see the recent pullback and product portfolio as supportive for long term value, and more cautious voices focused on competitive threats from perpetual futures and the potential impact on valuation multiples.
Analiz Makalesi • Jun 18

CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News

CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...
Anlatı Güncellemesi • Jun 05

CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power

Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.
Anlatı Güncellemesi • May 15

CME: Mixed Street Views And New Markets Will Shape Future Earnings Power

Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.
Anlatı Güncellemesi • Apr 27

CME: Volatile Street Views And New Futures Will Shape Trading Mix

Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.
Anlatı Güncellemesi • Apr 11

CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes

The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.
Anlatı Güncellemesi • Mar 26

CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix

Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.
Anlatı Güncellemesi • Mar 11

CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook

Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.
Anlatı Güncellemesi • Feb 25

CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook

The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.
Anlatı Güncellemesi • Feb 10

CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook

The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.
Anlatı Güncellemesi • Jan 27

CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook

The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.
Anlatı Güncellemesi • Jan 12

CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook

Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.
Anlatı Güncellemesi • Dec 27

CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks

Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.
Anlatı Güncellemesi • Dec 13

CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility

Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.
Anlatı Güncellemesi • Nov 16

CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead

The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:CME - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20287,7964,5135,1265,2307
12/31/20277,3614,4254,8164,93413
12/31/20267,0374,3894,3704,65213
6/30/20266,7574,2654,2134,309N/A
3/31/20266,7444,2354,3294,420N/A
12/31/20256,5074,0214,1944,277N/A
9/30/20256,3853,7174,0844,161N/A
6/30/20256,4333,7214,1074,196N/A
3/31/20256,2743,5813,8263,914N/A
12/31/20246,1203,4823,5973,691N/A
9/30/20246,0343,4223,6283,717N/A
6/30/20245,7883,2623,4923,571N/A
3/31/20245,6163,1573,3633,444N/A
12/31/20235,5793,1863,3773,454N/A
9/30/20235,3383,0113,3113,391N/A
6/30/20235,2282,9423,1083,192N/A
3/31/20235,1042,8283,0783,159N/A
12/31/20225,0192,6572,9663,056N/A
9/30/20224,8332,6332,6502,743N/A
6/30/20224,7152,8892,6162,717N/A
3/31/20224,6572,7452,4772,599N/A
12/31/20214,6902,6172,2752,402N/A
9/30/20214,6302,4352,2252,394N/A
6/30/20214,6001,9201,8882,074N/A
3/31/20214,6031,9132,3782,561N/A
12/31/20204,8842,1052,5182,716N/A
9/30/20204,9112,1512,5812,775N/A
6/30/20205,1092,3753,0713,274N/A
3/31/20205,2002,386N/A2,761N/A
12/31/20194,8682,117N/A2,673N/A
9/30/20194,9592,033N/A2,464N/A
6/30/20194,5881,808N/A2,236N/A
3/31/20194,3771,860N/A2,285N/A
12/31/20184,3091,962N/A2,441N/A
9/30/20183,9734,516N/A2,391N/A
6/30/20183,9594,413N/A2,316N/A
3/31/20183,8244,262N/A2,057N/A
12/31/20173,6454,063N/A1,751N/A
9/30/20173,6581,498N/A1,801N/A
6/30/20173,6091,662N/A1,773N/A
3/31/20173,5901,566N/A1,732N/A
12/31/20163,5951,534N/A1,732N/A
9/30/20163,4961,452N/A1,607N/A
6/30/20163,5051,340N/A1,591N/A
3/31/20163,4181,284N/A1,626N/A
12/31/20153,3271,247N/A1,533N/A
9/30/20153,3541,262N/A1,644N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CME 'nin tahmini kazanç büyümesi (yıllık 3.4% ) tasarruf oranının ( 3.7% ) altındadır.

Kazançlar ve Piyasa: CME şirketinin kazançlarının (yıllık 3.4% ) US pazarından (yıllık 17.1% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CME şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: CME şirketinin gelirinin (yıllık 5.1% ) US pazarından (yıllık 13% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CME şirketinin gelirinin (yıllık 5.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CME 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16.3 %).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/08/10 03:56
Gün Sonu Hisse Fiyatı2026/08/07 00:00
Kazançlar2026/06/30
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

CME Group Inc. 32 Bu analistlerden 13, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Stephen BiggarArgus Research Company
Benjamin BudishBarclays
Roger FreemanBarclays